Antidiabetic Suganon acquires approval as a complex
Dong-A ST, which developed Suganon(evogliptin), a domestic DPP-4 inhibitor, has quickly acquired approval of ‘Sugamet,’ a complex of evogliptin and metformin. It has only been 3 months since the approval of Suganon on October.
The Ministry of Food and Drug Safety approved Dong-A ST’s Sugamet Tab...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
